Clinical Study
Rapid Infusion Rituximab for Maintenance Therapy: Is It Feasible?
| Patient | 1 | 2 | 3 | Age (years) | 46 | 51 | 66 | Diagnosis | Low-grade follicular lymphoma | CLL/SLL | Marginal zone lymphoma | Treatment | CVP-R × 6 cycles | Weekly rituximab × 8 weeks | R-CHOP × 1 cycle followed by 4 weeks of weekly rituximab | Maintenance schedule | Q 3 months | Weekly × 4 weeks Q 6 months | Weekly × 4 weeks Q 6 months | Dose no. with reaction | 5 | Course 2, week 1 | (a) Course 3, week 1 (b) Course 3, week 2 | Grade of reaction | 3 | 1 | (a) 3 (b) 3 | Rapid rate rechallenge | No | Yes | Yes |
|
|